1. Home
  2. SGHT vs NHS Comparison

SGHT vs NHS Comparison

Compare SGHT & NHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGHT
  • NHS
  • Stock Information
  • Founded
  • SGHT 2011
  • NHS 2003
  • Country
  • SGHT United States
  • NHS United States
  • Employees
  • SGHT N/A
  • NHS N/A
  • Industry
  • SGHT Medical Specialities
  • NHS Trusts Except Educational Religious and Charitable
  • Sector
  • SGHT Health Care
  • NHS Finance
  • Exchange
  • SGHT Nasdaq
  • NHS Nasdaq
  • Market Cap
  • SGHT 193.2M
  • NHS 229.5M
  • IPO Year
  • SGHT 2021
  • NHS N/A
  • Fundamental
  • Price
  • SGHT $3.49
  • NHS $7.67
  • Analyst Decision
  • SGHT Buy
  • NHS
  • Analyst Count
  • SGHT 8
  • NHS 0
  • Target Price
  • SGHT $4.29
  • NHS N/A
  • AVG Volume (30 Days)
  • SGHT 108.2K
  • NHS 111.8K
  • Earning Date
  • SGHT 11-06-2025
  • NHS 01-01-0001
  • Dividend Yield
  • SGHT N/A
  • NHS 13.44%
  • EPS Growth
  • SGHT N/A
  • NHS N/A
  • EPS
  • SGHT N/A
  • NHS N/A
  • Revenue
  • SGHT $76,303,000.00
  • NHS N/A
  • Revenue This Year
  • SGHT N/A
  • NHS N/A
  • Revenue Next Year
  • SGHT $12.04
  • NHS N/A
  • P/E Ratio
  • SGHT N/A
  • NHS N/A
  • Revenue Growth
  • SGHT N/A
  • NHS N/A
  • 52 Week Low
  • SGHT $2.03
  • NHS $6.95
  • 52 Week High
  • SGHT $7.03
  • NHS $9.17
  • Technical
  • Relative Strength Index (RSI)
  • SGHT 49.70
  • NHS 70.69
  • Support Level
  • SGHT N/A
  • NHS $7.56
  • Resistance Level
  • SGHT $3.65
  • NHS $7.68
  • Average True Range (ATR)
  • SGHT 0.16
  • NHS 0.06
  • MACD
  • SGHT -0.19
  • NHS 0.02
  • Stochastic Oscillator
  • SGHT 82.12
  • NHS 93.75

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

About NHS Neuberger Berman High Yield Strategies Fund

Neuberger Berman High Yield Strategies Fund Inc is a diversified, closed-end management investment company. The company invests in high yield debt securities market. The Fund uses leverage to pursue its investment objective. The Fund may invest in a variety of direct debt instruments, including bank loans, notes and other interests in amounts owed to financial institutions by borrowers, such as companies and governments. Corporate loans in which the Fund may invest will consist of direct obligations of borrowers. The Fund may invest in corporate loans at origination as a co-lender or may acquire loans in the secondary market by purchasing participations in, assignments of or novations of corporate loans.

Share on Social Networks: